Laboratory of Physiopharmacology, University of Antwerp, Belgium.
Laboratory of Medical Biochemistry, University of Antwerp, Belgium.
FEBS Lett. 2020 Sep;594(18):3067-3075. doi: 10.1002/1873-3468.13878. Epub 2020 Jul 20.
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3) is a key enzyme of the glycolytic pathway, and it plays an essential role in angiogenesis. 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) is frequently used as a glycolysis inhibitor and is thought to inhibit PFKFB3. However, this latter effect of 3PO has never been investigated in detail and was the aim of the present study. To demonstrate binding of 3PO to PFKFB3, we used isothermal titration calorimetry. However, 3PO did not bind to PFKFB3, even up to 750 µm, in contrast to 3 µm of AZ67, which is a potent and specific PFKFB3 inhibitor. Instead, 3PO accumulated lactic acid inside the cells, leading to a decrease in the intracellular pH and an inhibition of enzymatic reactions of the glycolytic pathway.
6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶同工酶 3(PFKFB3)是糖酵解途径的关键酶,它在血管生成中起着至关重要的作用。3-(3-吡啶基)-1-(4-吡啶基)-2-丙烯-1-酮(3PO)常被用作糖酵解抑制剂,被认为可以抑制 PFKFB3。然而,3PO 对 PFKFB3 的这种抑制作用从未被详细研究过,这是本研究的目的。为了证明 3PO 与 PFKFB3 的结合,我们使用了等温滴定量热法。然而,3PO 甚至在高达 750µm 的浓度下也没有与 PFKFB3 结合,而 3µm 的 AZ67 是一种有效的、特异性的 PFKFB3 抑制剂。相反,3PO 在细胞内积累乳酸,导致细胞内 pH 值下降,并抑制糖酵解途径的酶促反应。
J Transl Med. 2012-5-16
Int J Mol Sci. 2021-5-31
Toxicol Appl Pharmacol. 2019-2-15
Front Endocrinol (Lausanne). 2025-6-17
Int J Mol Sci. 2025-3-7
Clin Exp Immunol. 2025-1-21
Front Mol Biosci. 2024-9-10
Mol Cancer. 2024-9-18